This Week in Hearing

This Week in Hearing

The place where subject matter experts across the "World of Hearing" come together to discuss all things hearing health, hearing aids, hearables, consumer audio, and everything in-between.

  1. Nov 11

    374 - One or Two Hearing Aids? What a New Study of 275 Adults Found

    For adults with hearing loss in both ears, audiologists have traditionally recommended two hearing aids, drawing on the well-established benefits of binaural hearing. However, the extent to which these benefits translate into improved outcomes with two hearing aids compared with one has been less thoroughly studied. Shari Eberts speaks with Sherri Smith, PhD, an audiologist and researcher at Duke University, about a new randomized clinical trial examining the benefits of one versus two hearing aids in adults with mild to moderate hearing loss. Eberts also served on the research team as lead patient advocate and co-lead of the stakeholder advisory team. Funded by the Patient-Centered Outcomes Research Institute (PCORI), the study enrolled 275 adults ages 50 and older who had never previously used hearing aids. After three months, participants fitted with two hearing aids reported approximately 5% greater benefit on the study's primary outcome measure compared with those fitted with one. However, both groups experienced improvement, and approximately 29% of participants ultimately chose one hearing aid. Smith explains what these findings mean for clinical recommendations, why affordability and patient preferences matter, and how audiologists can use patient-reported outcomes to better understand individual benefit. The conversation also explores the study's real-world design, the potential role of over-the-counter hearing aids, and the importance of involving people with hearing loss directly in clinical research. Smith and Eberts discuss the study's limitations, unanswered questions about the clinical significance of the observed differences, and how future research could help clinicians make more individualized recommendations. Learn more about the PCORI-funded study: https://www.pcori.org/research-results/2020/comparing-use-one-versus-two-hearing-aids-adults-mild-or-moderate-hearing-loss Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X. - https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearing Visit us at: https://hearinghealthmatters.org/thisweek/

    374 - One or Two Hearing Aids? What a New Study of 275 Adults Found
  2. Nov 4

    373 - Making Auracast Work in Theatres: GN and RNID's New Playbook

    Installing Auracast in a public venue is one thing. Making sure people with hearing loss can actually use it effectively is another. Reporting live from the GN Hearing booth at EUHA 2026, Andrew Bellavia speaks with Laurel Christensen, Chief Audiology Officer at GN Hearing; Alastair Moore, Technology Lead at RNID; and Gideon Hoffman, an experienced hearing technology user, about the new Auracast Theatre Playbook developed through a collaboration between GN and RNID.The conversation explores why the initiative goes beyond technical installation to address the complete listening experience, including reliable signal coverage, appropriate audio mixing, staff awareness, and communicating Auracast availability to patrons. Hoffman shares firsthand experiences with assistive listening systems, including theaters where Auracast coverage was inconsistent and a musical production where the broadcast omitted much of the music. The guests discuss how these challenges can be addressed by involving people with hearing loss in planning, testing, and evaluating installations.The discussion also considers how the Playbook can help audiologists, hearing aid users, and accessibility advocates encourage adoption in their communities. Although developed with theaters in mind, its recommendations have potential applications in conference centers, houses of worship, and other public venues worldwide. Learn more about the GN and RNID Auracast Theatre Playbook initiative:https://hearinghealthmatters.org/hearing-news-watch/2026/auracast-access-gn-rnid/ Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X. - https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

    373 - Making Auracast Work in Theatres: GN and RNID's New Playbook
  3. Oct 28

    372 - Therapeutic Interventions for Genetic Hearing Loss: Inside the SKY-GJB2 Trial

    Gene therapy is opening new possibilities for addressing the underlying causes of genetic hearing loss. Brian Taylor, AuD, is joined by Jodi Cook, CEO of Skylark Bio, and Alexa Kozak, AuD, to discuss emerging therapeutic interventions for inherited hearing loss, with a particular focus on GJB2-related hearing loss, commonly associated with the connexin 26 protein. They explain the role of GJB2 in cochlear function, how genetic mutations contribute to hearing loss, and the potential for gene therapy to target the underlying biological cause.The conversation explores Skylark Bio's investigational gene therapy, SKY-GJB2, which is being evaluated in the SONIX Phase 1/2 clinical trial involving children ages 9 months to 7 years. Designed to deliver a functional copy of the GJB2 gene to cells within the cochlea, the treatment is being studied for safety, tolerability, and preliminary efficacy. Cook and Kozak discuss the science behind the approach, the trial's design and early milestones, and how emerging genetic therapies might eventually complement established interventions such as hearing aids and cochlear implants.The discussion also highlights the growing importance of genetic testing in pediatric audiology, including how clinicians can help families identify the causes of hearing loss and access genetic counseling. As research advances toward potentially treating certain forms of hearing loss at the molecular level, the conversation offers perspective on the evolving role of audiologists in diagnosis, treatment planning, and emerging therapeutic care. Learn more about Skylark Bio and their SONIX trial here: https://www.skylarkbio.com/news/skylark-bio-doses-first-patient-in-sonix-phase-1-2-trial-of-sky-gjb2-for-gjb2-related-pediatric-deafness Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X. - https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

    372 - Therapeutic Interventions for Genetic Hearing Loss: Inside the SKY-GJB2 Trial
  4. Oct 22

    371 - How Audiologists Make Hearing Aid Selection Decisions: Insights from New Research

    How do audiologists decide which hearing aids to recommend to their patients? And how much of that decision is guided by scientific evidence versus clinical experience, patient listening needs, and traditional technology-tiering approaches? In this conversation, host Brian Taylor is joined by Rachael Pennock, AuD, a PhD student at Northwestern University, to discuss her recently published research examining how audiologists make hearing aid selection decisions and the factors that influence their recommendations. For decades, hearing aid manufacturers and clinicians have relied on a “good, better, best” approach to hearing aid technology, often matching premium devices with patients who report more demanding listening environments. But how well does the research support this familiar model? Drawing on two recent studies, including a survey of 185 audiologists and qualitative interviews exploring clinical decision-making, Pennock discusses how practitioners assess patients' listening environments, why informal clinical interviews remain a dominant assessment method, and how audiologists weigh technology levels, patient characteristics, and financial considerations. The conversation also explores the limitations of existing evidence comparing basic and premium hearing aids, the influence of clinical training and manufacturer messaging, and why more research is needed to determine which patients benefit most from advanced hearing aid technology. Articles Mentioned: Pennock, R., & Souza, P. (2026). Audiologist Decision-Making: Hearing Aid Technology Levels and Auditory Ecology. Journal of the American Academy of Audiology, 37(4), 280–297. https://doi.org/10.3766/jaaa.250077Pennock, R., Van Pelt, A., & Souza, P. (2026). Hearing Aid Selection by Audiologists: A Qualitative Exploration of Clinical Decision Making. American Journal of Audiology, 1–14. Advance online publication. https://doi.org/10.1044/2026_AJA-26-00063Mertes, I. B., Braun, S. T., & Billings, C. J. (2026). A Survey of U.S. Audiologists' Speech-in-Noise Testing Practice Patterns for Adults. American Journal of Audiology, 1–18. Advance online publication.https://doi.org/10.1044/2026_AJA-25-00332Miller, B. (2026). The Regret Gap: How Tiered Counseling Disconnects Clinical Need from Intervention, Part 1. Audiology Practices, 17(4), 9–19.Miller, B. (2026). Closing the Regret Gap, Part 2: The Minimum Clinical Need Framework. Audiology Practices, 18(1), 22–33. Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X. - https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

    371 - How Audiologists Make Hearing Aid Selection Decisions: Insights from New Research
  5. Oct 13

    370 - Inside Starkey Omega AI+ Hearing Aids: Quad DNN, Better Speech and New Health Features

    Starkey's new Omega AI+ hearing aids introduce a Quad DNN processing architecture, enhanced speech-in-noise technology, improved feedback management, and new sleep-tracking capabilities. But what do these advancements mean for hearing aid users and hearing care professionals?Reporting from Starkey Day in Minneapolis, Andrew Bellavia speaks with three of Starkey's senior leaders to explore the technology behind Omega AI+ and the company's broader vision for hearing health.Sarah Burdack, Chief Audiology Officer, discusses improvements in speech clarity, listening comfort, and feedback management, including Starkey's reported 11 dB improvement in feedback gain margin compared with its previous Omega generation. She also explains how Edge Mode allows users to prioritize speech, comfort, or overall sound quality, with an option for continuous operation.Achin Bhowmik, Chief Technology Officer, takes a deeper look at the new Quad DNN architecture, including neural-network-based compression, directionality, spatial awareness, and speech enhancement. He also explains how Starkey is using hearing aid sensors to introduce sleep tracking, including information about sleeping position.Brandon Sawalich, President and CEO, discusses Starkey's long-term technology roadmap, the growing role of hearing aids in health monitoring, and opportunities to improve the patient experience beyond the devices themselves.The conversation also examines practical considerations, including the updated charger, proactive left-behind notifications, and the continued emphasis on battery performance. Finally, Andrew puts one question to the test: How comfortable is it to sleep while wearing receiver-in-canal hearing aids?Watch for an in-depth look at Omega AI+ and how Starkey is combining artificial intelligence, hearing performance, and health technology in its latest generation of hearing aids. Starkey Omega AI+ launch announcement:https://hearinghealthmatters.org/hearing-technologies/2026/omega-ai-plus-g4-hearing-aids/ Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X. - https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

    370 - Inside Starkey Omega AI+ Hearing Aids: Quad DNN, Better Speech and New Health Features
  6. Oct 7

    369 - We Value Hearing — So Why Is Hearing Loss Still So Misunderstood?

    Nearly half (48%) of U.S. adults say society doesn’t know enough about hearing loss — even though people overwhelmingly recognize the importance of good hearing.In this conversation, Shari Eberts speaks with Dr. Patrick D’Haese, Corporate Director of Awareness and Public Affairs at MED-EL, about findings from a new international survey of more than 10,000 adults across 10 countries. The results reveal a striking disconnect between how much people value hearing and how well hearing loss is understood.They explore why hearing loss can be so easy to overlook, the listening effort that often remains invisible to others, gaps in awareness around cochlear implants and other hearing solutions, and some surprising findings about age and hearing-device stigma. The discussion also considers how greater public understanding could help people recognize hearing difficulties and seek support sooner.The conversation closes with a broader question for hearing healthcare: Should hearing checks become as routine as eye exams, blood pressure checks, cholesterol screenings, and dental visits? MED-EL 2026 global survey: https://www.medel.com/press-room/press-list/press-details/2026/07/09/global-med-el-survey-reveals--people-value-hearing-highly---but-few-believe-society-understands-hearing-lossBe sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X. - https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

    369 - We Value Hearing — So Why Is Hearing Loss Still So Misunderstood?
  7. Sep 29

    368 - Listen Up: A New Push to Make Hearing Screening Routine at 50

    Hearing loss often develops gradually, which means many people may not recognize changes until they begin interfering with everyday communication. A new national initiative is looking to change that by making hearing screening a routine part of healthy aging.Shari Eberts is joined by Dr. Jill Davis, President of the Academy of Doctors of Audiology (ADA), and Mike O’Neil, U.S. Wholesale President at WSA, to discuss 'Listen Up', a public awareness campaign encouraging adults to begin routine hearing screening at age 50.The conversation explores why age 50 was selected as a starting point, the value of establishing a hearing baseline before noticeable problems emerge, and how screening can support prevention and earlier intervention. Davis and O’Neil also discuss the campaign’s grassroots approach, its expansion following an initial Kentucky pilot, and efforts to bring hearing screening into primary care and other settings where adults already receive routine health screenings.They also address hearing protection, online and remote screening options, when a comprehensive audiologic evaluation may be appropriate, and how Listen Up aims to make hearing health a more familiar part of the broader healthy-aging conversation. The initiative is currently expanding into Texas, Florida, Colorado, and Illinois as ADA and WSA test locally focused approaches to increasing public awareness.The goal is simple: make checking your hearing at 50 as routine as other health screenings—and give people a baseline they can track over time. Learn more about Listen Up and access campaign resources, consumer materials, and downloadable PSAs: https://audiologist.org/listenupBe sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X. - https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

    368 - Listen Up: A New Push to Make Hearing Screening Routine at 50
  8. Sep 16

    367 - Oticon Reveal Hearing Aids: Inside the New Dual AI Technology

    Oticon’s new Reveal hearing aid platform introduces a Dual AI approach designed to manage speech and contextual sounds while preserving the broader sound environment around the listener. Andrew Bellavia visits the Oticon Reveal U.S. launch at OticonNext in San Diego for an in-depth look at the technology with Michael Lamberson, President of Oticon USA, and Thomas Behrens, Vice President of Hearing Aid Audiology.They explore how Reveal differs from Oticon Intent, including two deep neural networks running on a single processing chip. Speech AI identifies and tracks speech across frequencies, while Context AI uses that information to manage surrounding sounds and noise. Rather than completely isolating a speaker, Oticon’s approach aims to create greater contrast between speech and background sound while maintaining contextual information from the surrounding environment.The conversation examines how clinicians can personalize the balance between speech and contextual sound, 360-degree access to the listening environment, and automatic adaptation across situations ranging from restaurants and group conversations to music. Bellavia, Lamberson, and Behrens also discuss listening effort, cognitive load, memory, and Oticon’s research into how hearing aid processing affects the brain.They also take a closer look at Reveal’s expanded fitting range, feedback management, IP68 rating, battery life, and wind noise processing, with Oticon reporting up to 10 dB of additional wind noise suppression compared with previous devices. The discussion also covers updated connectivity hardware, Auracast, LE Audio, MFi, and other wireless protocols, before concluding with a broader look at how Oticon is approaching the continued use of AI and deep neural networks in hearing aids.Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X. - https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

    367 - Oticon Reveal Hearing Aids: Inside the New Dual AI Technology

Ratings & Reviews

5
out of 5
2 Ratings

About

The place where subject matter experts across the "World of Hearing" come together to discuss all things hearing health, hearing aids, hearables, consumer audio, and everything in-between.

You Might Also Like